The drugmaker unexpectedly cuts its full-year guidance, citing lower sales expectations for its blockbuster drugs Wegovy and ...

Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

Novo Nordisk stock collapsed 26% in its worst trading day ever after slashing guidance on Wegovy sales and naming a new CEO.

The announcement came amid a slump in the company's share price and investor concerns about its experimental drug pipeline ...

Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...

Shares in Danish drugmaker Novo Nordisk were down nearly 20% in pre-market trading Tuesday morning after the company cuts its ...

Ozempic (semaglutide) and other GLP-1 medications have helped many people lose weight and manage chronic conditions like type ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

A new analysis of 11 global studies shows that people tend to regain lost weight after stopping anti-obesity medications like ...

Similar to other popular weight loss drugs, including Ozempic, Rybelsus, and Wegovy, Zepbound mimics the GLP-1 hormone, a hormone in the stomach that regulates sugar levels and appetite.

Most of the scariest side effects of weight-loss drugs like Ozempic, Wegovy, and Zepbound have been gastrointestinal. Patients using these injectable GLP-1 medications have shared horror stories about ...